Celyad Oncology SA
CLYYF
$0.65
-$0.03-4.41%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.35M | 4.68M | 6.67M | 6.72M | 7.74M |
| Total Receivables | 939.00K | 1.01M | 1.16M | 1.17M | 3.07M |
| Inventory | 431.70K | 465.10K | -- | -- | -- |
| Prepaid Expenses | 979.40K | 1.06M | 1.40M | 1.41M | 1.39M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 46.60K | 50.20K | 41.80K | 42.10K | 85.10K |
| Total Current Assets | 6.75M | 7.27M | 9.28M | 9.35M | 12.29M |
|
|
|||||
| Total Current Assets | 6.75M | 7.27M | 9.28M | 9.35M | 12.29M |
| Net Property, Plant & Equipment | 1.55M | 1.67M | 1.79M | 1.80M | 2.02M |
| Long-term Investments | 0.00 | 0.00 | -- | -- | 0.00 |
| Goodwill | 0.00 | 0.00 | -- | -- | 0.00 |
| Total Other Intangibles | 23.80K | 25.70K | 27.90K | 28.10K | 53.10K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.96M | 2.12M | 2.67M | 2.69M | 3.63M |
| Total Assets | 10.28M | 11.07M | 13.76M | 13.86M | 18.00M |
|
|
|||||
| Total Accounts Payable | 1.28M | 1.38M | 1.14M | 1.14M | 1.37M |
| Total Accrued Expenses | 458.60K | 494.10K | 378.20K | 380.80K | 548.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 147.00K | 158.40K | 166.10K | 167.20K | 172.40K |
| Total Finance Division Other Current Liabilities | 1.06M | 1.15M | 908.60K | 914.90K | 1.15M |
| Total Other Current Liabilities | 1.06M | 1.15M | 908.60K | 914.90K | 1.15M |
| Total Current Liabilities | 2.95M | 3.17M | 2.59M | 2.61M | 3.24M |
|
|
|||||
| Total Current Liabilities | 2.95M | 3.17M | 2.59M | 2.61M | 3.24M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 789.90K | 851.00K | 893.60K | 899.80K | 997.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.01M | 6.48M | 6.78M | 6.83M | 6.79M |
| Total Liabilities | 9.75M | 10.50M | 10.27M | 10.34M | 11.03M |
|
|
|||||
| Common Stock & APIC | 8.51M | 9.16M | 8.80M | 8.86M | 36.42M |
| Retained Earnings | -377.05M | -406.20M | -387.25M | -389.92M | -396.12M |
| Treasury Stock & Other | 369.08M | 397.60M | 381.94M | 384.58M | 366.67M |
| Total Common Equity | 529.00K | 569.90K | 3.50M | 3.52M | 6.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 529.00K | 569.90K | 3.50M | 3.52M | 6.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 529.00K | 569.90K | 3.50M | 3.52M | 6.97M |
|
|
|||||